The ERYTHROMYCIN STEARATE TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, special_features: COATING FEATURE:NONENERTIC FILM, primary_container_type: BOTTLE, therapeutic_equivalent: VANGARD LABS., medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 250.000 TABLETS. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-218-3860, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | COATING FEATURE:NONENERTIC FILM |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | VANGARD LABS. |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 250.000 TABLETS |
| active_medicament_medicinal_strength | 250.000 MILLIGRAMS ERYTHROMYCIN EQUIVALENT |
| NSN | 6505-01-218-3860 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| THERAPEUTIC EQUIVALENT | VANGARD LABS. |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | COATING FEATURE:NONENERTIC FILM |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS ERYTHROMYCIN EQUIVALENT |
| PRIMARY CONTAINER CONTENT QUANTITY | 250.000 TABLETS |
| ADMINISTRATION | ORAL |